SRINIVASAN RAJARAMAN, MBBS
Medical Practice at University Blvd, Galveston, TX

License number
Texas F8988
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
301 University Blvd, Galveston, TX 77555
Phone
(409) 772-0817
(409) 772-0885 (Fax)

Personal information

See more information about SRINIVASAN RAJARAMAN at radaris.com
Name
Address
Phone
Srinivasan Rajaraman, age 81
3215 Dominique Dr, Galveston, TX 77551
(409) 740-1835
Srinivasan Rajaraman
Galveston, TX
(409) 740-1835
Srinivasan Rajaraman
3215 Dominique Dr, Galveston, TX 77551
(409) 740-1835
Srinivasan Rajaraman
418 Stasney, Buckholts, TX 77840
(979) 691-8382
Srinivasan Rajaraman
418 Stasney St, College Station, TX 77840
(979) 691-8382

Organization information

See more information about SRINIVASAN RAJARAMAN at bizstanding.com

Srinivasan Rajaraman MD,MBBS

301 University Blvd, Galveston, TX 77555

Site:
Phone:
(409) 772-0817 (Phone)
Description:
There are 18 doctors at this site. Surgery is not performed at this site.
Srinivasan Rajaraman

Professional information

Srinivasan Rajaraman Photo 1

Dr. Srinivasan Rajaraman, Galveston TX - MD (Doctor of Medicine)

Specialties:
Anatomic & Clinical Pathology
Address:
3215 Dominique Dr, Galveston 77551
(409) 740-1835 (Phone), (409) 740-1835 (Fax)
301 University Blvd, Galveston 77555
(409) 772-0817 (Phone), (409) 772-0885 (Fax)
Certifications:
Anatomic & Clinical Pathology, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3215 Dominique Dr, Galveston 77551
301 University Blvd, Galveston 77555
University of Texas Medical Branch Galveston
301 University Blvd, Galveston 77555
Education:
Medical School
Thanjavur Medical College
Nj Coll Med
W Va U Sch Med
Cleveland Clinic Foundation


Srinivasan Rajaraman Photo 2

Assay For Free Secretory Component And Methods For Monitoring Organ Rejection

US Patent:
5340721, Aug 23, 1994
Filed:
Jul 26, 1991
Appl. No.:
7/736448
Inventors:
Randall M. Goldblum - Dickinson TX
Srinivasan Rajaraman - Galveston TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 33543, G01N 33566
US Classification:
435 792
Abstract:
Methods of monitoring and detecting the early onset of organ injury incident rejection of an organ rejection in an animal are disclosed. The described methods are capable of distinguishing organ rejection injury from other organ tissue damage in the animal. Free secretory component levels in an animal biological fluid (e. g. , bile, urine, blood, amniotic fluid) may be used to identify organ rejection in an animal. Multiple and single organ transplant patients may be monitored and diagnosed according to the claimed methods. Biological fluids, such as blood, (serum) or urine, are analyzed immunologically using a particularly adapted ELISA which are then compared to an FSC control concentration to identify elevated FSC values. Animals with test FSC above FSC control concentrations are diagnosed as having an ongoing organ rejection episode. The detection of congenital renal dysfunction in utero is also provided according to the present invention through the measurement of FSC in the amniotic fluid.


Srinivasan Rajaraman Photo 3

Assay For Free Secretory Component And Methods For Monitoring Organ Rejection

US Patent:
5484707, Jan 16, 1996
Filed:
Dec 28, 1993
Appl. No.:
8/174670
Inventors:
Randall M. Goldblum - Dickinson TX
Srinivasan Rajaraman - Galveston TX
Assignee:
The Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 33543, G01N 33566
US Classification:
435 792
Abstract:
Methods of monitoring and detecting the early onset of organ injury incident rejection of a organ rejection in an animal are disclosed. The described methods are capable of distinguishing organ rejection injury from other organ tissue damage in the animal. Free secretory component levels in an animal biological fluid (e. g. , bile, urine, blood, amniotic fluid) may be used to identify organ rejection in an animal. Multiple and single organ transplant patients may be monitored and diagnosed according to the claimed methods. Biological fluids, such as blood, (serum) or urine, are analyzed immunologically using a particularly adapted ELISA which are then compared to an FSC control concentration to identify elevated FSC values. Animals with test FSC above FSC control concentrations are diagnosed as having an ongoing organ rejection episode. The detection of congenital renal dysfunction in utero is also provided according to the present invention through the measurement of FSC in the amniotic fluid.